These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6753485)

  • 21. Participation of a histamine-Sepharose-adherent subpopulation of human mononuclear cells in the production of leucocyte migration inhibition factor (LIF) in healthy children.
    Reichman BL; Handzel ZT; Segal S; Weinstein Y; Levin S
    Clin Exp Immunol; 1979 Sep; 37(3):562-6. PubMed ID: 389498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cyclic GMP-agonists on cyclosporin-induced suppression of human lymphokine production.
    Svenson M; Bendtzen K
    Allergy; 1985 Oct; 40(7):529-34. PubMed ID: 3000211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T cell subsets differ in their ability to migrate in vitro and to produce T cell migration inhibitory factor.
    Kowalczyk D; Pryjma J; Zembala M
    Immunol Lett; 1986 Aug; 13(1-2):33-8. PubMed ID: 2944820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of LIF production but not blastogenesis in patients with tuberculous meningitis.
    Joffe MI; Rabson AR
    Clin Immunol Immunopathol; 1981 Feb; 18(2):245-53. PubMed ID: 7008992
    [No Abstract]   [Full Text] [Related]  

  • 26. Suppression of lymphokine production. I. Macrophage-mediated inhibition of MIF production.
    Varesio L; Holden HT
    Cell Immunol; 1980 Nov; 56(1):16-28. PubMed ID: 6253087
    [No Abstract]   [Full Text] [Related]  

  • 27. Migration inhibition and stimulation factors produced from peripheral blood lymphocyte cultures of sensitised guinea pigs.
    Matsui Y; Oshima S
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):151-5. PubMed ID: 3907650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chloramphenicol on in vitro function of lymphocytes.
    DaMert GJ; Sohnle PG
    J Infect Dis; 1979 Feb; 139(2):220-4. PubMed ID: 438534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of lymphokine-producing lymphocytes from aged humans to undergo activation by recall antigens.
    Sohnle PG; Larson SE; Collins-Lech C; Guansing AR
    J Immunol; 1980 May; 124(5):2169-74. PubMed ID: 6988514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Fc receptor-bearing lymphocytes by immune complexes. I. Stimulation of lymphokine production by nonadherent human peripheral blood lymphocytes.
    Neville ME; Lischner HW
    J Immunol; 1982 Mar; 128(3):1063-9. PubMed ID: 6173417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte regulation of lymphokine production in cancer patients.
    Kowalczyk D; Ruggiero I; Zembala M
    J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of human lymphoid cell line lymphokine preparations (LCL-LK) as working standards in the bioassay of human leucocyte migration inhibition factor (LIF).
    Hamblin AS; Zawisza B; Shipton U; Dumonde DC; Den Hollander FC; Verheul H
    J Immunol Methods; 1982 Nov; 54(3):317-29. PubMed ID: 6757327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus.
    Szigeti R; Masucci MG; Masucci G; Aman P; Klein G; Klein E
    Immunol Lett; 1985; 9(5):267-73. PubMed ID: 2987111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of hydrocortisone (HC) on sodium periodate and phytohemagglutinin-induced [3H]thymidine incorporation and lymphokine production by human lymphocytes.
    Lomnitzer R; Phillips R; Rabson AR
    Clin Immunol Immunopathol; 1983 Jun; 27(3):378-86. PubMed ID: 6307572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific lymphokine responses in cervical nodes of patients with laryngeal cancer.
    Cortesina G; Beatrice F; Morra B; Barioglio MG; Poggio E; Bussi M; DiFortunato V; Sacchi M; Rendine S; Sartoris A
    Laryngoscope; 1987 Jul; 97(7 Pt 1):843-7. PubMed ID: 3298902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator production by human monocytes. I. Enhancement by activated lymphocytes and lymphocyte products.
    Greineder DK; Connorton KJ; David JR
    J Immunol; 1979 Dec; 123(6):2808-13. PubMed ID: 501090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential in vitro effects of etretinate and retinoic acid on the PHA and con A induced lymphocyte transformation, suppressor cell induction and leukocyte migration inhibitory factor (LMIF) production.
    Soppi E; Tertti R; Soppi AM; Toivanen A; Jansén CT
    Int J Immunopharmacol; 1982; 4(5):437-43. PubMed ID: 6215368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of human lymphocyte function by C3a and C3a(70-77).
    Payan DG; Trentham DE; Goetzl EJ
    J Exp Med; 1982 Sep; 156(3):756-65. PubMed ID: 7050289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2).
    Dayer JM; Trentham DE; Krane SM
    Coll Relat Res; 1982 Nov; 2(6):523-40. PubMed ID: 6301748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.